⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for oxaliplatin

Every month we try and update this database with for oxaliplatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)NCT05564403
Recurrent Bilia...
Recurrent Dista...
Recurrent Gallb...
Recurrent Intra...
Stage III Dista...
Stage III Hilar...
Stage III Intra...
Stage IV Distal...
Stage IV Hilar ...
Stage IV Intrah...
Unresectable Bi...
Unresectable Di...
Unresectable Ga...
Unresectable In...
Binimetinib
Biopsy
Biospecimen Col...
Bone Scan
Computed Tomogr...
Echocardiograph...
Fluorouracil
Leucovorin Calc...
Magnetic Resona...
Multigated Acqu...
Oxaliplatin
18 Years - National Cancer Institute (NCI)
Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With HepatomaNCT00861783
Hepatoma
Advanced Solid ...
irinotecan and ...
oxaliplatin and...
18 Years - Traws Pharma, Inc.
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid TumorsNCT06139211
Advanced Solid ...
JS015
Toripalimab
Paclitaxel
Irinotecan
Capecitabine
Oxaliplatin
Bevacizumab
Fluorouracil
Leucovorin
Gemcitabine
Albumin-Bound P...
18 Years - 75 YearsShanghai Junshi Bioscience Co., Ltd.
Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously TreatedNCT00025337
Adenocarcinoma ...
Adenocarcinoma ...
Recurrent Colon...
Recurrent Recta...
Stage III Colon...
Stage III Recta...
Stage IV Colon ...
Stage IV Rectal...
bevacizumab
oxaliplatin
leucovorin calc...
fluorouracil
18 Years - National Cancer Institute (NCI)
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China ExtensionNCT04882241
Gastric Cancer
Gastroesophagea...
Pembrolizumab
Placebo
Cisplatin
Capecitabine
5-fluorouracil
Docetaxel
Oxaliplatin
Leucovorin
18 Years - Merck Sharp & Dohme LLC
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the LiverNCT00492999
Colorectal Canc...
Metastatic Canc...
dexamethasone
floxuridine
fluorouracil
irinotecan hydr...
leucovorin calc...
oxaliplatin
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal CancerNCT00016198
Colorectal Canc...
FOLFOX regimen
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic MarkersNCT02296671
Esophagogastric...
Pemetrexed
Oxaliplatin
Leucovorin
Fluorouracil
Germline genoty...
18 Years - Washington University School of Medicine
Oxaliplatin in Treating Children With Advanced Solid TumorsNCT00005844
Unspecified Chi...
oxaliplatin
- 21 YearsSt. Jude Children's Research Hospital
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerNCT00274885
Cancer
oxaliplatin
management of t...
18 Years - National Cancer Institute (NCI)
HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular CarcinamaNCT04627363
Hepatocellular ...
Bevacizumab
Liver Neoplasms
Toripalimab
Oxaliplatin
Hepatic arteria...
Bevacizumab
Toripalimab
18 Years - 75 YearsSun Yat-sen University
XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based ChemotherapyNCT02350686
Biliary Tract C...
capecitabine
oxaliplatin
18 Years - Samsung Medical Center
Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal CancerNCT04518280
Locally Advance...
PD-1 antibody
Capecitabine
Oxaliplatin
Short-course ra...
18 Years - 70 YearsFudan University
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) CancerNCT02954536
Esophageal Canc...
Gastric Cancer
pembrolizumab
trastuzumab
capecitabine
cisplatin
Oxaliplatin
5-Fluorouracil
18 Years - Memorial Sloan Kettering Cancer Center
Total Neoadjuvant Therapy of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer (ENSEMBLE)NCT05646511
Locally Advance...
SCRT
CAPOX
CAPOXIRI
18 Years - National Cancer Center Hospital East
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal CancerNCT00640081
Colorectal Canc...
cetuximab
capecitabine
fluorouracil
leucovorin calc...
oxaliplatin
immunohistochem...
laboratory biom...
18 Years - 100 YearsMedical Research Council
Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal CancerNCT00613080
Colorectal Canc...
capecitabine
oxaliplatin
resection
radiation thera...
FOLFOX
18 Years - Radiation Therapy Oncology Group
Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric CancersNCT03515941
Gastrointestina...
Oxaliplatin
Capecitabine
Leucovorin
5-fluorouracil
radiation
18 Years - Baylor College of Medicine
Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL.NCT01670370
Diffuse Large B...
R-GemOx
60 Years - The First Affiliated Hospital with Nanjing Medical University
Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCCNCT03812770
Hepatocellular ...
Sorafenib
HAIC of FOLFOX
HAIC of OXA
18 Years - 75 YearsSun Yat-sen University
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell LymphomaNCT04408638
Diffuse Large B...
Obinutuzumab
Glofitamab
Rituxumab
Tocilizumab
Gemcitabine
Oxaliplatin
18 Years - Hoffmann-La Roche
Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on NeoantigenNCT04340401
Rectal Cancer
SHR-1210
Oxaliplatin
Capecitabine
Intensity modul...
Total mesorecta...
18 Years - 70 YearsPeking University Cancer Hospital & Institute
Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerNCT00049101
Colorectal Canc...
erlotinib hydro...
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRCNCT03222089
Metastatic Colo...
Irinotecan
Oxaliplatin
Levoleucovorin
5-FU
GM-CSF
IL-2
18 Years - 75 YearsFujian Cancer Hospital
Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal CancerNCT04703101
Locally Advance...
Rectal Adenocar...
Stage II Rectal...
Stage IIA Recta...
Stage IIB Recta...
Stage IIC Recta...
Stage III Recta...
Stage IIIA Rect...
Stage IIIB Rect...
Stage IIIC Rect...
Capecitabine
Fluorouracil
Intensity-Modul...
Leucovorin
Oxaliplatin
Quality-of-Life...
Surveillance
Total Mesorecta...
18 Years - Jonsson Comprehensive Cancer Center
Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before SurgeryNCT03000374
Rectal Cancer
Panitumumab
5Fluorouracil
Oxaliplatin
Leucovorin
18 Years - 74 YearsGrupo Espanol Multidisciplinario del Cancer Digestivo
Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver InvolvementNCT00537823
Colorectal Canc...
Metastases
Cetuximab
Bevacizumab
Leucovorin
Oxaliplatin
Fluorouracil
18 Years - Washington University School of Medicine
FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal CancerNCT02063529
Metastatic Colo...
FOLFOXIRI + Cet...
FOLFOXIRI
18 Years - 65 YearsSun Yat-sen University
Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal CancerNCT00062426
Colorectal Canc...
bevacizumab
capecitabine
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric CancerNCT03745170
Gastric Cancer
Sintilimab
Oxaliplatin
Capecitabine
placebo
18 Years - Innovent Biologics (Suzhou) Co. Ltd.
Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal CancerNCT02497157
Metastatic Colo...
Oxaliplatin (L-...
Irinotecan hydr...
Continuous intr...
Levofolinate ca...
Bevacizumab (Bm...
20 Years - 70 YearsTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerNCT00080951
Colorectal Canc...
fluorouracil
irinotecan hydr...
leucovorin calc...
oxaliplatin
18 Years - 120 YearsAlliance for Clinical Trials in Oncology
Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal CancerNCT06225622
Metastatic Colo...
Irinotecan Lipo...
Oxaliplatin
5-FU
LV
Bevacizumab
Cetuximab
18 Years - 75 YearsShanghai Zhongshan Hospital
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical CancerNCT00057863
Cervical Adenoc...
Cervical Adenos...
Cervical Squamo...
Recurrent Cervi...
Stage IVA Cervi...
Stage IVB Cervi...
Paclitaxel
Oxaliplatin
18 Years - National Cancer Institute (NCI)
Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal CarcinomaNCT03585673
Esophagus Squam...
Metastatic Canc...
Docetaxel-PM
Oxaliplatin
18 Years - Dong-A University Hospital
Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon CancerNCT04488159
Colon Cancer St...
Capecitabine
Oxaliplatin
Fluorouracil
Leucovorin
ImmunoscoreÂŽ as...
Physical exerci...
18 Years - 100 YearsMedical University of Vienna
SHOrt Course Radiation and TASOX (TAS102 Plus Oxaliplatin) Chemotherapy in Operable Rectal CancerNCT04417699
Rectal Cancer
TAS 102
Oxaliplatin
18 Years - Providence Health & Services
Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon CancerNCT00096278
Colon Adenocarc...
Stage IIA Colon...
Stage IIB Colon...
Stage IIC Colon...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Bevacizumab
Fluorouracil
Leucovorin Calc...
Oxaliplatin
18 Years - National Cancer Institute (NCI)
A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic CarcinomaNCT02539537
Pancreatic Canc...
Carcinoma
Gemcitabine
Folinic Acid
5-Fluoro-uracil
Oxaliplatin
Irinotecan
L-folinic
18 Years - UNICANCER
Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal CancerNCT00571740
Colorectal Canc...
bevacizumab
cetuximab
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - Alliance for Clinical Trials in Oncology
Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid TumorNCT00005839
Unspecified Adu...
capecitabine
oxaliplatin
18 Years - City of Hope Medical Center
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal CancerNCT00642603
Colorectal Canc...
capecitabine [X...
capecitabine [X...
bevacizumab [Av...
oxaliplatin
irinotecan
18 Years - Hoffmann-La Roche
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerNCT00008281
Colorectal Canc...
FOLFOX regimen
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal CancerNCT02842580
Colorectal Neop...
5 FLUOROURACYL
acide folinique
irinotecan
Oxaliplatin
capĂŠcitabine
bevacizumab
18 Years - Federation Francophone de Cancerologie Digestive
Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon CancerNCT04488159
Colon Cancer St...
Capecitabine
Oxaliplatin
Fluorouracil
Leucovorin
ImmunoscoreÂŽ as...
Physical exerci...
18 Years - 100 YearsMedical University of Vienna
Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal CancerNCT05479240
Immunotherapy
Tislelizumab
Capecitabine
oxaliplatin
short-range rad...
18 Years - 75 YearsFujian Cancer Hospital
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal CancerNCT01231399
Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Esoph...
Recurrent Gastr...
Stage IV Esopha...
Stage IV Gastri...
fluorouracil
leucovorin calc...
oxaliplatin
everolimus
laboratory biom...
immunohistochem...
microarray anal...
19 Years - City of Hope Medical Center
Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel ChemotherapiesNCT04361708
Pancreatic Aden...
Gastroesophagea...
Adenocarcinoma
Oxaliplatin
Docetaxel
Leucovorin
Irinotecan
5-Fluorouracil
18 Years - University of Chicago
Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) AdenocarcinomaNCT04097028
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Trifluridine an...
Oxaliplatin
18 Years - Roswell Park Cancer Institute
Oxaliplatin in Rectal CancerNCT00259363
Rectal Neoplasm...
Oxaliplatin
18 Years - 80 YearsSanofi
Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerNCT00268411
Pancreatic Canc...
gemcitabine hyd...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer PatientNCT01955629
Colorectal Canc...
Aflibercept AVE...
Oxaliplatin
Capecitabine
18 Years - Sanofi
Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic CancerNCT00323583
Adenocarincoma ...
Stage III Pancr...
Stage IVA Pancr...
Stage IVB Pancr...
paclitaxel
oxaliplatin
leucovorin
5-fluorouracil
glutathione
calcium and mag...
Chemotherapy
Chemoprotection
Complementary a...
18 Years - 65 YearsSeattle Cancer Treatment and Wellness Center
Gemox as First and Second Line Therapy in Unknown Primary CancerNCT00353145
Unknown Primary...
Gemcitabine (Ge...
Oxaliplatin
Questionnaire
18 Years - M.D. Anderson Cancer Center
A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid TumorsNCT02715531
Solid Tumor
5-FU
Atezolizumab
Bevacizumab
Gemcitabine
Leucovorin
Nab-Paclitaxel
Oxaliplatin
Capecitabine
Cisplatin
18 Years - Hoffmann-La Roche
Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerNCT00049101
Colorectal Canc...
erlotinib hydro...
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon CancerNCT01442155
Colorectal Canc...
Capecitabine
Oxaliplatin
18 Years - Hoffmann-La Roche
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal CancerNCT00200200
Hepatic Metasta...
Colon Cancer
Rectal Cancer
Bevacizumab HAI...
HAI plus system...
19 Years - Memorial Sloan Kettering Cancer Center
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II StudyNCT02345460
Pancreatic Aden...
Poorly Differen...
Resectable Panc...
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
Undifferentiate...
Irinotecan Hydr...
Oxaliplatin
Leucovorin Calc...
Fluorouracil
Laboratory Biom...
18 Years - 75 YearsCase Comprehensive Cancer Center
Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic CancerNCT00871169
Pancreatic Canc...
Irinotecan, oxa...
18 Years - New Mexico Cancer Care Alliance
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric AdenocarcinomaNCT04150640
Esophageal Aden...
Gastric Adenoca...
Nal-IRI
Oxaliplatin
5-FU
Trastuzumab
Pembrolizumab
Nivolumab
18 Years - University of Wisconsin, Madison
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)NCT04210115
Esophageal Squa...
Gastroesophagea...
Esophageal Aden...
pembrolizumab
placebo
cisplatin
5-FU
radiotherapy
leucovorin
levoleucovorin
oxaliplatin
18 Years - Merck Sharp & Dohme LLC
Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal CancerNCT00008060
Colorectal Canc...
FOLFIRI regimen
FOLFOX regimen
fluorouracil
irinotecan hydr...
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction CarcinomaNCT03469557
Esophageal Squa...
Tislelizumab
Cisplatin
5-FU
Oxaliplatin
Capecitabine
18 Years - 75 YearsBeiGene
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal CancerNCT00068692
Rectal Mucinous...
Rectal Signet R...
Recurrent Recta...
Stage IIA Recta...
Stage IIB Recta...
Stage IIC Recta...
Stage IIIA Rect...
Stage IIIB Rect...
Stage IIIC Rect...
Stage IVA Recta...
Stage IVB Recta...
Radiotherapy
Fluorouracil
Leucovorin Calc...
Oxaliplatin
Irinotecan
18 Years - National Cancer Institute (NCI)
A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.NCT00454636
Gastric Cancer
Cisplatin
Capecitabine
Epirubicin
Cisplatin
Capecitabine
Oxaliplatin
Docetaxel
Capecitabine
18 Years - Hoffmann-La Roche
EloxatinÂŽ Plus Gemcitabine Chemotherapy for MesotheliomaNCT00859469
Mesothelioma
Oxaliplatin
Gemcitabine
18 Years - Columbia University
Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal CancerNCT00462501
Colorectal Canc...
bevacizumab
fluorouracil
leucovorin calc...
oxaliplatin
conventional su...
radiation thera...
18 Years - Memorial Sloan Kettering Cancer Center
Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC SessionsNCT06313801
Gastric Cancer
Docetaxel
Oxaliplatin
Calcium folinat...
Fluorouracil
Diagnostic lapa...
dPIPAC ( The de...
18 Years - 75 YearsNizhny Novgorod Regional Clinical Oncology Center
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid TumorsNCT00138177
Recurrent Colon...
Recurrent Recta...
Stage III Colon...
Stage III Recta...
Stage IV Colon ...
Stage IV Rectal...
Unspecified Adu...
oxaliplatin
leucovorin calc...
vorinostat
fluorouracil
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal CancerNCT00482222
Colorectal Canc...
Metastatic Canc...
cetuximab
capecitabine
fluorouracil
leucovorin calc...
oxaliplatin
study of socioe...
adjuvant therap...
neoadjuvant the...
quality-of-life...
18 Years - University of Southampton
Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric CancerNCT04982939
Gastric Cancer
Perioperative
Sintilimab
Sintilimab
S-1
Oxaliplatin
18 Years - 75 YearsTianjin Medical University Cancer Institute and Hospital
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerNCT00217737
Colon Mucinous ...
Colon Signet Ri...
Lynch Syndrome
Stage IIA Colon...
Stage IIB Colon...
Stage IIC Colon...
Bevacizumab
Fluorouracil
Laboratory Biom...
Leucovorin Calc...
Oxaliplatin
18 Years - National Cancer Institute (NCI)
A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal CancerNCT00865189
Rectal Cancer
Bevacizumab
Oxaliplatin
Folinic Acid
5-fluorouracil
Preoperative Ra...
Surgery
18 Years - 75 YearsHoffmann-La Roche
PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal CancerNCT04301557
DMMR Colorectal...
MSI-H Colorecta...
Locally Advance...
PD-1 Antibody
Oxaliplatin
Capecitabine
External beam r...
Total mesorecta...
18 Years - 72 YearsSun Yat-sen University
GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon CancerNCT00262808
Colorectal Canc...
sargramostim
fluorouracil
leucovorin calc...
oxaliplatin
adjuvant therap...
conventional su...
neoadjuvant the...
18 Years - University of Rochester
A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell LymphomaNCT04313608
B-cell Lymphoma
Glofitamab
Gemcitabine
Oxaliplatin
Mosunetuzumab
Obinutuzumab
Tocilizumab
18 Years - Hoffmann-La Roche
Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver DysfunctionNCT00005077
Unspecified Adu...
oxaliplatin
18 Years - City of Hope Medical Center
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerNCT00551759
Esophageal Canc...
5-Fluorouracil
Oxaliplatin
Cetuximab
Docetaxel
Surgery
Radiotherapy
18 Years - Eastern Cooperative Oncology Group
HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)NCT04447352
Gastric Cancer
Gastroesophagea...
5-Fluorouracil
Leucovorin
Oxaliplatin
Docetaxel
Cisplatin
18 Years - 75 YearsKrankenhaus Nordwest
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: